Literature DB >> 16670938

Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.

Shawn C Chen1, Oscar W Cummings, Michael P Hartley, Carol A Filomena, Won Kyoo Cho.   

Abstract

Hepatocellular carcinoma is known to be associated with underlying liver diseases, such as cirrhosis, hemochromatosis, and chronic viral hepatitis. All reported cases of hepatocellular carcinoma in association with Crohn's disease involve patients treated previously with azathioprine or both azathioprine and steroids. However, hepatocellular carcinoma associated with the use of azathioprine and infliximab has not been reported. In this report, we describe an unusual case of hepatocellular carcinoma and focal hepatic glycogenosis (FHG) occurring in a non-cirrhotic Crohn's disease patient who has been treated with both azathioprine and infliximab.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16670938     DOI： 10.1007/s10620-005-9009-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  7 in total

1.  Unusual development of hepatocellular carcinoma in a patient with Crohn's disease.

Authors:  M L Borum
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  De novo hepatocellular carcinoma without chronic liver disease but with 17 years of azathioprine immunosuppression.

Authors:  S Gruber; L P Dehner; R L Simmons
Journal:  Transplantation       Date:  1987-04       Impact factor: 4.939

3.  Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine.

Authors:  F L Lee; S M Murray; J Prior; D R Shreeve
Journal:  Hepatogastroenterology       Date:  1983-10

4.  Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis.

Authors:  S Russmann; A Zimmermann; S Krähenbühl; B Kern; J Reichen
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-03       Impact factor: 2.566

5.  Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy.

Authors:  S Cattan; D Wendum; O Chazouilleres; J Schmitz; J P Gendre
Journal:  Hum Pathol       Date:  2000-07       Impact factor: 3.466

6.  Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: a case series.

Authors:  K Saeian; J Franco; R A Komorowski; M B Adams
Journal:  Liver Transpl Surg       Date:  1999-01

7.  Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab.

Authors:  Adam C Esser; Andy Abril; Scott Fayne; John A Doyle
Journal:  J Am Acad Dermatol       Date:  2004-05       Impact factor: 11.527
  7 in total
  11 in total

1.  Hepatocellular carcinoma occurring in a Crohn's disease patient.

Authors:  Mitsuaki Ishida; Shigeyuki Naka; Hisanori Shiomi; Tomoyuki Tsujikawa; Akira Andoh; Tamio Nakahara; Yasuharu Saito; Yoshimasa Kurumi; Mikiko Takikita-Suzuki; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

2.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

3.  Hepatocellular Carcinoma Regression After Cessation of Immunosuppressive Therapy.

Authors:  Abhijeet Kumar; Dung T Le
Journal:  J Clin Oncol       Date:  2014-09-22       Impact factor: 44.544

Review 4.  [Hepatocellular carcinoma in the non-cirrhotic liver].

Authors:  M Evert; F Dombrowski
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

5.  Infliximab in the treatment of Crohn's disease.

Authors:  Gilberto Poggioli; Silvio Laureti; Massimo Campieri; Filippo Pierangeli; Paolo Gionchetti; Federica Ugolini; Lorenzo Gentilini; Piero Bazzi; Fernando Rizzello; Maurizio Coscia
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

6.  Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review.

Authors:  Kyle J Fortinsky; Ali Alali; Khursheed Jeejeebhoy; Sandra Fischer; Morris Sherman; Scott Fung
Journal:  Case Rep Gastrointest Med       Date:  2014-12-22

7.  Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?

Authors:  Youssef Botros; Mary Mathews; Hiren Patel; Nihar Shah; Walid Baddoura; Andrew de la Torre
Journal:  Case Rep Gastrointest Med       Date:  2015-12-14

Review 8.  Novel Immunotherapies for Autoimmune Hepatitis.

Authors:  Shamir Cassim; Marc Bilodeau; Catherine Vincent; Pascal Lapierre
Journal:  Front Pediatr       Date:  2017-01-26       Impact factor: 3.418

Review 9.  Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.

Authors:  My-Linh Tran-Minh; Paula Sousa; Marianne Maillet; Matthieu Allez; Jean-Marc Gornet
Journal:  World J Hepatol       Date:  2017-05-08

10.  Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.

Authors:  Ravish Parekh; Nirmal Kaur
Journal:  Case Rep Gastrointest Med       Date:  2014-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.